PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Develops New Treatment Model, Announces Co-Sponsorship of First-Ever Trial to Treat Frontline Clinicians

Jun 8, 2021

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has developed EMBARK, a transdiagnostic psychotherapy model, and will be co-sponsoring an upcoming trial designed for frontline clinicians experiencing COVID-related distress. Cybin announced that the randomized, placebo-controlled trial will evaluate psychedelic-assisted psychotherapy with psilocybin in the treatment of  symptoms of depression, anxiety, burnout and post-traumatic stress among doctors, nurses and healthcare professionals on the frontlines of COVID-19. EMBARK is a groundbreaking psychotherapy model that integrates leading clinical approaches aimed at promoting supportive healing with psychedelic medicine. Cybin is collaborating with a University of Washington team, led by Dr. Anthony Back, in sponsoring the trial. In the announcement, the company noted that the nation’s doctors, nurses and clinicians have been shouldering the burden of COVID-19 by taking care of the sickest COVID-19 patients and, as a result, have been experiencing high levels of anxiety, depression and burnout. “For more than a year now, frontline clinicians and healthcare professionals have made immeasurable sacrifices to protect public health in their communities,” said Cybin CEO Doug Drysdale in the press release. “We consider it an honor and our duty to now help support their own healing processes, post-COVID-19. We are also delighted and proud to launch EMBARK, a groundbreaking psychotherapy model aimed at delivering best-practice, supportive healing in conjunction with psychedelic therapeutics. We look forward to working with and supporting Dr. Anthony Back on this important program.”

To view the full press release, visit https://ibn.fm/yCBlo

About Cybin Inc.

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics for mental illness and addiction by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

More News

X2, Troubled Six Flags Roller Coaster, to Close After Lawsuits
Sep 30, 2026
X2, Troubled Six Flags Roller Coaster, to Close After Lawsuits

The ride at Magic Mountain near Los Angeles has fueled lawsuits claiming that it had caused brain injuries, including two that were fatal.

The volunteers baking birthday cakes for children
Sep 30, 2026
The volunteers baking birthday cakes for children

The Hampshire group says it has seen a rise in demand and it needs more volunteer bakers.

Regulating AI 'not the right place to start' says Bailey
Sep 30, 2026
Regulating AI 'not the right place to start' says Bailey

AI needs "rigorous" testing and safeguards to contain risk, Andrew Bailey says.

DeepSeek and Huawei Target a Key Source of Nvidia’s A.I. Dominance
Sep 30, 2026
DeepSeek and Huawei Target a Key Source of Nvidia’s A.I. Dominance

In China’s push for self-reliance in artificial intelligence, DeepSeek and Huawei have teamed up to develop software tools for advanced chips.

Greggs to cut 740 jobs and close factories
Sep 30, 2026
Greggs to cut 740 jobs and close factories

High street bakery brand Greggs has announced plans to shut four of its factories and cut 740 jobs.

Bracing for More Inflation Volatility
Sep 30, 2026
Bracing for More Inflation Volatility

Consumers, business owners and investors are growing increasingly concerned about rising inflation, and its potential repercussions.

Africa's richest man launches Kenya oil refinery despite land protests
Sep 30, 2026
Africa's richest man launches Kenya oil refinery despite land protests

The Kenya refinery is part of Dangote's ambitious bid to expand and help industralise Africa by 2030.

Pie shop owner gets reply from Andy Burnham
Sep 30, 2026
Pie shop owner gets reply from Andy Burnham

Chorley businessman, Paul Bowen received a reply from Prime Minister Andy Burnham, after posting a video on social media about the closure of one of his shops due to the state of the high street.

Trump’s New Tariffs Face a Familiar Court Challenge
Sep 30, 2026
Trump’s New Tariffs Face a Familiar Court Challenge

For the third time in less than two years, the Trump administration is set to return to court on Wednesday to defend its power to wage a punishing global trade war.

Trump’s New Tariffs Face a Familiar Court Challenge
Sep 30, 2026
Trump’s New Tariffs Face a Familiar Court Challenge

For the third time in less than two years, the Trump administration is set to return to court on Wednesday to defend its power to wage a punishing global trade war.

How to Listen to Your Favorite Music, Online or Off the Grid
Sep 30, 2026
How to Listen to Your Favorite Music, Online or Off the Grid

Streaming services can introduce you to a wonderland of nearly unlimited audio, but downloading your digital collection has advantages.

Doubters spur me on: why more women are taking up DIY
Sep 30, 2026
Doubters spur me on: why more women are taking up DIY

Female DIY experts and tradeswomen talk about their experiences of a traditionally male-dominated domain.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Marketers Log

Marketers Log is your personal Business & Finance news site to provide marketing or market-related news.

Newsletter